AAV8 gene therapy shows promise, but new scalable platform overcomes manufacturing challenges for consistent production.

If 2025 taught us that trust can be weaponised, then 2026 will teach us how to rebuild trust in a safer, more deliberate way.

India ranging from contaminated cough syrups and product alerts, a sharp dengue season in several states, extreme-heat ...

As the Edmonton Oilers continue to hover in the muddy middle of the Western Conference, each passing day brings the gloom a ...

Downside liquidity clusters near $140 suggest volatility ahead as Solana (SOL) trades around $132 after a 16% monthly drop.

CTM’s Joint Venture (“JV”), SSI, and our two mentor protégé JVs all awarded Missile Defense Agency (“MDA”) SHIELD Multiple Award IDIQ Contracts to support national defense objectives by ensuring ...

The government is set to pilot a project to quantify climate-related health impacts by integrating climate and health data into early warning systems, officials have announced.

FOXO Technologies Inc. (OTC: FOXO) (“FOXO” or the “Company”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., was recently recognized by the Rural Health ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

Previously, we watched Tim Berners-Lee knit the world together with the Web, giving us pages to browse and links to click. But a web of information is ...

Operational real-world data analyzed from patients prescribed ZYNTEGLO™ and LYFGENIA™Data demonstrates the value proposition of one-time, durable gene therapy for the treatment of sickle cell disease ...

Please refer to the ASH 2025 online program for full session details and visit the Genetix booth (#1261) onsite.